Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$333M |
| 2 |
Alibaba
BABA
|
+$303M |
| 3 |
Pfizer
PFE
|
+$269M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
Eversource Energy
ES
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$780M |
| 2 |
Linde
LIN
|
+$623M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$515M |
| 4 |
S&P Global
SPGI
|
+$449M |
| 5 |
UnitedHealth
UNH
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.66% |
| 2 | Healthcare | 13.63% |
| 3 | Financials | 11.69% |
| 4 | Communication Services | 9.98% |
| 5 | Consumer Discretionary | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
1276
DELISTED
Acceleron Pharma
XLRN
| $6.34M | ﹤0.01% |
119,591
+2,622
| +2% | +$120K |
|
|
CHCT
1277
Community Healthcare Trust
CHCT
$530M
| $6.33M | ﹤0.01% |
147,688
-223
| -0.2% | -$10.2K |
|
1278
Anika Therapeutics
ANIK
$242M
| $6.32M | ﹤0.01% |
122,000
+111,804
| +1,097% | +$6.49M |
|
1279
BHP
BHP
$218B
| $6.32M | ﹤0.01% |
129,472
-172,743
| -57% | -$7.85M |
|
1280
Progress Software
PRGS
$1.65B
| $6.31M | ﹤0.01% |
151,845
-121,533
| -44% | -$4.94M |
|
1281
Madison Square Garden
MSGS
$9.75B
| $6.29M | ﹤0.01% |
30,000
+26,130
| +675% | +$5.13M |
|
|
CALY
1282
Callaway Golf Company
CALY
$3.33B
| $6.27M | ﹤0.01% |
295,704
+237,733
| +410% | +$4.87M |
|
1283
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
| $6.27M | ﹤0.01% |
68,631
-7
| -0% | -$638 |
|
1284
Southwest Gas
SWX
$6.54B
| $6.26M | ﹤0.01% |
82,398
+50,081
| +155% | +$4.07M |
|
|
CATM
1285
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $6.25M | ﹤0.01% |
140,059
+13,452
| +11% | +$511K |
|
|
DOC
1286
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $6.2M | ﹤0.01% |
327,586
-133,959
| -29% | -$2.46M |
|
|
WPX
1287
DELISTED
WPX Energy, Inc.
WPX
| $6.19M | ﹤0.01% |
450,753
+295,014
| +189% | +$3.15M |
|
1288
Vanguard FTSE Developed Markets ETF
VEA
$230B
| $6.19M | ﹤0.01% |
140,507
-6,107
| -4% | -$260K |
|
1289
Qualys
QLYS
$4.99B
| $6.15M | ﹤0.01% |
73,827
-21,494
| -23% | -$1.78M |
|
|
KRTX
1290
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $6.15M | ﹤0.01% |
81,680
+30,418
| +59% | +$1.33M |
|
1291
Koppers
KOP
$942M
| $6.14M | ﹤0.01% |
160,720
+147,173
| +1,086% | +$5.17M |
|
1292
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $6.11M | ﹤0.01% |
100,457
+1,588
| +2% | +$96.7K |
|
|
SPLP
1293
DELISTED
STEEL PARTNERS HOLDINGS L.P.
SPLP
| $6.11M | ﹤0.01% |
504,800
+489,300
| +3,157% | +$6M |
|
|
FRTA
1294
DELISTED
Forterra, Inc
FRTA
| $6.11M | ﹤0.01% |
528,493
+515,530
| +3,977% | +$5.01M |
|
1295
Barclays
BCS
$93.4B
| $6.09M | ﹤0.01% |
639,760
-1,274,300
| -67% | -$11M |
|
1296
Tactile Systems Technology
TCMD
$636M
| $6.08M | ﹤0.01% |
90,004
-16,177
| -15% | -$895K |
|
|
DERM
1297
DELISTED
Dermira, Inc.
DERM
| $6.07M | ﹤0.01% |
400,343
+39,584
| +11% | +$342K |
|
|
GMS
1298
DELISTED
GMS Inc
GMS
| $6.06M | ﹤0.01% |
223,770
-169,954
| -43% | -$4.99M |
|
|
AVTA
1299
DELISTED
Avantax, Inc. Common Stock
AVTA
| $6.06M | ﹤0.01% |
231,808
-18,841
| -8% | -$422K |
|
1300
NMI Holdings
NMIH
$3.3B
| $6.05M | ﹤0.01% |
182,506
+145,143
| +388% | +$4.53M |
|
Similar funds
Deutsche Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Deutsche Bank held 5,318 positions worth $153B, up 6.6% from $144B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Deutsche Bank withdrew a net $5.3B in Q4 2019, closing 262 positions and reducing 1,924 holdings. Its most notable exit was Celgene Corp, an estimated $273M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Deutsche Bank opened a new position in XP worth $32.9M.
- Deutsche Bank's largest Q4 2019 buy was XP: 853,950 shares worth $32.9M.
- Deutsche Bank added most to Johnson & Johnson in Q4 2019, an estimated $333M increase.
- Deutsche Bank's biggest Q4 2019 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $780M.
- Deutsche Bank fully exited Celgene Corp in Q4 2019, selling an estimated $273M.
- Deutsche Bank's ten largest holdings make up 17% of its $153B portfolio in Q4 2019.
- Deutsche Bank opened 407 new positions and closed 262 in Q4 2019.
- Deutsche Bank's portfolio value rose 6.6% quarter-over-quarter to $153B.
Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.